Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 30, 2025Annual Review of Cancer Biology

lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy Resistance

View Full Paper
Ask AI
Bookmark
Share

Authors

ELEleonora Leucci

Discussion

Loading...

Member takes

Overview

This review highlights how lncRNAs affect cancer progression in cells, suggesting they are actionable therapeutic targets for resistance.

Key Points

  • Cancer progression is influenced by lncRNAs acting as regulators of biomolecules in cancer cells, emphasizing their roles in oncogenic networks.
  • Key findings reveal actionable therapeutic targets among lncRNAs relevant to cancer therapy resistance, highlighting their regulatory potential.
  • This review synthesizes insights into the involvement of lncRNAs as molecular scaffolds and sponges in cancers.
  • Understanding lncRNAs may provide new strategies to address therapy resistance in cancer treatment and improve outcomes.

Cite This Study

Eleonora Leucci (2025) studied this question.

synapsesocial.com/papers/692b94261d383f2b2a37832chttps://doi.org/10.1146/annurev-cancerbio-071124-012245
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy Resistance2025
  2. 2The role of long non-coding RNAs in therapy resistance of cervical cancer and therapeutic potential2026
  3. 3Long non-coding RNAs in cancer stem cells and therapeutic resistance2026
  4. 4Decoding long non‑coding RNAs: Friends and foes in cancer development (Review)2024 · 3 citations
  5. 5Long Non-Coding RNAs in HER2-Positive Breast Cancer: From Resistance Mechanisms to Translational Potential2026